SE386904B - Forfarande for framstellning av 3-oxigenerad 1,2alfa-metylen-6,7alfa-di-fluormetylen-20-spiroxa-4-en-21-on samt estrar derav - Google Patents

Forfarande for framstellning av 3-oxigenerad 1,2alfa-metylen-6,7alfa-di-fluormetylen-20-spiroxa-4-en-21-on samt estrar derav

Info

Publication number
SE386904B
SE386904B SE7303114A SE311473A SE386904B SE 386904 B SE386904 B SE 386904B SE 7303114 A SE7303114 A SE 7303114A SE 311473 A SE311473 A SE 311473A SE 386904 B SE386904 B SE 386904B
Authority
SE
Sweden
Prior art keywords
estrars
oxygened
2alfa
7alfa
spiroxa
Prior art date
Application number
SE7303114A
Other languages
English (en)
Swedish (sv)
Inventor
G E Arth
G H Rasmusson
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE386904B publication Critical patent/SE386904B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7303114A 1969-05-14 1970-05-13 Forfarande for framstellning av 3-oxigenerad 1,2alfa-metylen-6,7alfa-di-fluormetylen-20-spiroxa-4-en-21-on samt estrar derav SE386904B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82467269A 1969-05-14 1969-05-14
US2118370A 1970-03-19 1970-03-19

Publications (1)

Publication Number Publication Date
SE386904B true SE386904B (sv) 1976-08-23

Family

ID=26694377

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7303114A SE386904B (sv) 1969-05-14 1970-05-13 Forfarande for framstellning av 3-oxigenerad 1,2alfa-metylen-6,7alfa-di-fluormetylen-20-spiroxa-4-en-21-on samt estrar derav
SE06534/70A SE366305B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1969-05-14 1970-05-13

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE06534/70A SE366305B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1969-05-14 1970-05-13

Country Status (17)

Country Link
JP (1) JPS532865B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR192305A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE750330A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA926385A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH547785A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (2) CS151552B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2023450C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (3) DK126992B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (2) FI47355C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2051526B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1265444A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE34194B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL34431A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL168844C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO131131C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (2) SE386904B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU34052B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356677A (en) * 1966-04-05 1967-12-05 Syntex Corp 1alpha, 2alpha-and 6alpha, 7alpha-dihalomethylene androstenes

Also Published As

Publication number Publication date
FI47355B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-07-31
DK127880B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-28
AR192305A1 (es) 1973-02-14
NL168844C (nl) 1982-05-17
JPS532865B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-02-01
FI47885B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-02
CS151551B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-10-19
BE750330A (fr) 1970-11-13
DE2023450B2 (de) 1978-10-05
IE34194B1 (en) 1975-03-05
FI47355C (fi) 1973-11-12
FI47885C (fi) 1974-04-10
CA926385A (en) 1973-05-15
IL34431A0 (en) 1970-07-19
DK127880C (da) 1974-06-10
FR2051526B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-04-12
CH547792A (de) 1974-04-11
NO131131C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-04-09
CH547785A (de) 1974-04-11
SE366305B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-04-22
DK127505B (da) 1973-11-19
NL7006474A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-11-17
IE34194L (en) 1970-11-14
NO131131B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-12-30
DE2023450A1 (de) 1971-01-14
DK126992B (da) 1973-09-10
DE2023450C3 (de) 1979-05-31
YU34052B (en) 1978-10-31
CS151552B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-10-19
IL34431A (en) 1974-03-14
NL168844B (nl) 1981-12-16
YU117670A (en) 1978-05-15
FR2051526A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1971-04-09
GB1265444A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-03-01

Similar Documents

Publication Publication Date Title
SE382459B (sv) Forfarande for framstellning av xantonderivat.
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE376568B (sv) Dekorationsspanskiva samt foerfarande foer framstaellning av densamma
SE390969B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner
SE399427B (sv) Forfarande for framstellning av 2,4 diamino-bensylpyrimidiner
FI55258B (fi) Drivspegelprojektil samt foerfarande foer fastsaettning av en projektilkropp i densamma
FI49723C (fi) Menetelmä antidepressiivisesti vaikuttavien -morfolino-p-amino-butyro fenonien sekä niiden suolojen valmistamiseksi.
SE390303B (sv) Forfarande for framstellning av isotiokarbamider med h?712-blockerande effekt
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
BG17560A3 (bg) Метод за получаане на 4,20, 22- буфатриеноли- драмнозид- етери
SE7511680L (sv) Forfarande for framstellning av furanderivat
ZA708410B (en) New evomonoside derivatives and the preparation thereof
SE7507565L (sv) Oligomera n-alkyl-imminoalaner samt forfarande for framstellning av desamma.
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
NO136049C (no) Fremgangsm}te til fremstilling av 16beta-metyl-9alfa-fluor-11beta,17alfa-21-trihydroksy-1,4-pregnadien-3,20-dion samt dets 21-acylater.
SE418962B (sv) Kompositkropp samt forfarande for framstellning av kompositkroppen
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
SE383521B (sv) Forfarande for framstellning av kardenolid-3-(2',3-dedesoxi-2,'3'-oxido-glykosider).
ZA708566B (en) New derivatives of neriifolin and the preparation thereof
SE398878B (sv) Forfarande for framstellning av substituerade 2,4-diamino-5-bensylpyrimidiner
SE389333B (sv) Forfarande for framstellning av ackalipolyfosfatkomplex av x-6-desoxi-5-hydroxitetsacyklin.
SE373577B (sv) Forfarande for framstellning av 3-cyklopentyleter av 7Ÿ -metyl- 3, 16Ÿ 17-trihydroxi-Ÿ1,3,5(10)-ostratrien samt 16, 17-diacetat derav
FI45175C (fi) Menetelmä 18-metyyli-19-nor-17alfa-hydroksi-progesteronien ja niiden 1 7alfa-esterien valmistamiseksi.
SE401366B (sv) Forfarande for framstellning av 2,6-metano-3-bensazociner
SE386904B (sv) Forfarande for framstellning av 3-oxigenerad 1,2alfa-metylen-6,7alfa-di-fluormetylen-20-spiroxa-4-en-21-on samt estrar derav